Cholesterol Hinders LNP Intracellular Trafficking

Lipid nanoparticles (LNPs) are among the most advanced nonviral systems for delivering siRNA, mRNA, and other nucleic acids. Their performance depends not only on cellular uptake but also on what happens after endocytosis: the particle must progress through the endosomal network and release its cargo before degradation. The study Intracellular trafficking of lipid nanoparticles is hindered by cholesterol, published in International Journal of Pharmaceutics in 2025, examines how LNP composition affects this intracellular itinerary.

Study Background and Research Question

LNPs commonly contain an ionizable lipid, a phospholipid such as DSPC, cholesterol, and a PEG-lipid. The ionizable lipid is generally near-neutral at physiological pH, which can reduce nonspecific interactions, but becomes protonated in acidic endosomes. This behavior supports nucleic acid association during formulation and can contribute to membrane destabilization during endosomal escape. DSPC helps organize the particle structure, while cholesterol can fill hydrophobic gaps, influence particle stability, and affect interactions with biological membranes.

Although these components are often discussed in terms of particle formation and endosomal escape, the route between uptake and release is less clearly understood. The central question was therefore whether individual lipid components change the intracellular trafficking of LNP-associated nucleic acids, rather than merely changing total uptake or bulk delivery. The authors focused on the distribution of LNP–DNA complexes among endocytotic vesicles, early endosomes, and later endolysosomal compartments.

This distinction matters experimentally. A formulation can enter cells efficiently yet remain trapped in a compartment that does not support productive release. Measuring uptake alone may consequently overestimate delivery potential.

Key Innovation from the Reference Study

The principal innovation was a sensitive LNP/nucleic acid tracking platform built around a streptavidin–biotin-DNA complex and high-throughput imaging. This strategy enabled the researchers to examine where nucleic acid-associated particles accumulated inside cells and how their localization changed with formulation variables. The approach shifts analysis from a single endpoint, such as total cellular fluorescence, toward a spatial and trafficking-oriented assessment.

A second strength was the use of deliberately designed LNP comparisons. The study separated the effect of increasing the ionizable lipid from the effect of increasing cholesterol and also examined whether DSPC could modify cholesterol-associated behavior. This is important because changing one formulation parameter can unintentionally alter several physical properties at once. The authors’ design attempted to identify which component was most closely associated with peripheral endosomal accumulation.

The resulting model is more nuanced than the assumption that greater ionizable lipid content automatically improves intracellular delivery. In the reported experiments, the N/P ratio and cholesterol content produced different trafficking phenotypes. That distinction provides a mechanistic basis for refining LNP composition beyond conventional optimization of uptake or apparent transfection potency.

Methods and Experimental Design Insights

The researchers compared naked nucleic acids with nucleic acids delivered using LNPs. Naked nucleic acids were used as a reference for endocytosis-dependent retention, whereas LNP-associated cargo was followed through the endolysosomal pathway. High-throughput imaging allowed analysis of intracellular patterns across many cells, making it possible to detect both general trafficking behavior and localized populations of trapped vesicles.

Formulations were evaluated across changes in N/P ratio, lipid concentration, cholesterol content, and helper-lipid composition. In one key comparison, the N/P ratio was increased together with the concentration of all lipids. Additional formulation designs then tested whether the resulting peripheral endosome phenotype was attributable specifically to the ionizable lipid or to another component. The paper reports that increasing ionizable lipid content alone did not reproduce the cholesterol-associated accumulation.

The study also assessed the spatial character of endocytosis. At lower formulation conditions, LNP–DNA uptake was described as largely monophasic. With increasing N/P ratio and concomitant lipid concentration, the pattern became biphasic, with a population of LNP-containing vesicles accumulating near the cell periphery and associated with early endosomes. This spatial readout was essential because the same total uptake can have different delivery consequences depending on whether particles continue toward later endolysosomal compartments.

Protocol Parameters

• Tracking platform: Use a streptavidin–biotin-DNA tracking design when the experimental objective is to resolve intracellular cargo localization rather than measure uptake alone, as implemented in the reference study.
• N/P comparison: Include a low-N/P condition; the study observed endolysosomal transport at an N/P ratio as low as 2, despite weak nucleic acid–LNP interaction.
• Component isolation: When increasing N/P ratio, separately test ionizable lipid content and cholesterol content instead of interpreting the N/P effect as a single mechanistic variable.
• Compartment analysis: Score peripheral early-endosome accumulation and progression toward later endolysosomal compartments as distinct outcomes; this is a workflow recommendation derived from the study’s trafficking logic.
• Helper-lipid control: Include DSPC-containing comparator formulations when assessing cholesterol-related aggregation, because DSPC alleviated the detrimental aggregation phenotype in the reported experiments.

Core Findings and Why They Matter

First, naked nucleic acids remained in endocytotic vesicles in proportion to endocytosis activity. This result establishes that uptake and productive trafficking are not interchangeable measurements. It also provides a baseline against which the transport effect of LNPs can be evaluated.

Second, LNPs redirected nucleic acids along the endolysosomal pathway even when the N/P ratio was as low as 2. The authors observed this behavior under conditions characterized by very weak nucleic acid–LNP interaction. Thus, efficient intracellular movement did not require the strongest apparent association between cargo and particle. This finding cautions against using formulation binding strength as a standalone predictor of delivery.

Third, increasing N/P ratio while increasing total lipid concentration changed the uptake pattern from monophasic to biphasic. A distinct population of LNP–DNA-containing vesicles accumulated in peripheral early endosomes. Importantly, increasing ionizable lipid content alone did not account for this phenotype. The result separates the effect of total formulation exposure from the specific effect of the ionizable lipid.

The most consequential observation concerned cholesterol. Increasing cholesterol content, either through dose or concentration changes, was positively associated with the formation and aggregation of peripheral LNP-containing early endosomes. These trapped particles showed reduced progression through the endolysosomal pathway and therefore had less access to compartments linked to cargo release. The authors conclude that high cholesterol content hinders intracellular trafficking and diminishes delivery efficiency.

DSPC moderated this effect. In the tested designs, the helper lipid alleviated cholesterol-associated aggregation, suggesting that the balance between neutral structural lipids may be as important as the absolute amount of cholesterol. The broader implication is that cholesterol should not be treated as an automatically beneficial structural component. Its contribution is formulation- and context-dependent, and excess cholesterol may create a trafficking liability even when cellular uptake remains evident.

Comparison with Existing Internal Articles

The internal article 10 mM dNTP Mixture: Elevating DNA Synthesis in PCR Workflows focuses on reproducible DNA synthesis, PCR optimization, and practical reagent handling. Its emphasis is complementary to the reference study: the LNP paper addresses intracellular transport after delivery, whereas the internal guide concerns preparation and amplification of DNA materials used in molecular workflows.

A second resource, Maximizing Assay Precision with 10 mM dNTP Mixture, discusses assay consistency in cell-based and DNA synthesis settings. That perspective is useful when designing reporter preparation or analytical controls, but it should not be interpreted as evidence that nucleotide composition resolves cholesterol-dependent trafficking. The reference paper identifies LNP composition and intracellular compartmentalization as the relevant determinants of the reported phenotype.

Limitations and Transferability

The findings provide a strong mechanistic hypothesis for cholesterol-dependent trafficking, but several boundaries should guide interpretation. Imaging localization demonstrates where labeled complexes accumulate; it does not, by itself, establish the precise molecular event that causes vesicle aggregation or prove that every peripheral compartment is incapable of release. Orthogonal measurements of particle structure, endosomal membrane disruption, cargo release, and functional expression would strengthen the causal chain.

Transferability also depends on formulation details. Ionizable lipid chemistry, lipid ratios, PEG-lipid abundance, particle size, nucleic acid identity, cell type, serum environment, and exposure conditions can all influence uptake and trafficking. The cholesterol effect observed in the study should therefore be tested rather than assumed to apply identically to every LNP platform. In particular, changing cholesterol may affect several particle properties simultaneously, so matched physicochemical characterization is needed when comparing formulations.

Why this cross-domain matters, maturity, and limitations

The connection to DNA synthesis workflows is practical but limited. A well-controlled DNA synthesis reagent can support preparation of DNA reporters, standards, or assay controls for trafficking experiments; it cannot correct a formulation that is trapped in peripheral early endosomes. A 2'-deoxyribonucleoside-5'-triphosphate mixture is therefore an upstream workflow resource, while cholesterol balance and intracellular routing remain LNP design questions. The evidence is sufficiently mature to justify compartment-resolved screening, but not to define a universal cholesterol threshold or a single optimal DSPC-to-cholesterol ratio.

Research Support Resources

For DNA amplification, reporter preparation, or related in vitro polymerization steps, researchers can use the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture (SKU K1041). The product information describes an equimolar aqueous solution containing dATP, dCTP, dGTP, and dTTP at 10 mM each, neutralized to pH 7.0. It can serve as a DNA synthesis reagent, PCR nucleotide mix, or DNA sequencing nucleotide mix in appropriate protocols. Storage at −20°C or below and aliquoting to limit freeze–thaw cycles are recommended by the product information.